ResearcherSapienza University of RomeNo recent work listed
Edoardo Francini
Matched on ORCID iD 0000-0003-4270-7023; OpenAlex author ID A5036125918. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 2
- Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or meta… Last author DOI 10.1016/j.jgo.2019.08.008↗
- Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study. Last author DOI 10.1007/s00280-015-2683-1↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roberto Petrioli · 2 shared papers, 2015–2020 · strength 0.17
- Paper Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for ol… DOI 10.1016/j.jgo.2019.08.008↗
- Paper Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a… DOI 10.1007/s00280-015-2683-1↗
- Giandomenico Roviello · 1 shared paper, 2015 · strength 0.06
- Daniele Marrelli · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.